While many prominent health influencers scrambled for safe responses or stayed silent entirely following President Trump’s claims about Tylenol and autism, Dr. Rhonda Patrick stepped forward with the scientific context that others seemed reluctant to provide.
The controversy erupted Monday when Trump announced that pregnant women should avoid acetaminophen entirely, declaring “With Tylenol, don’t take it. Don’t take it.” According to sources, his administration directed the FDA to notify doctors about supposed increased autism risks, surprising the medical community and leaving expectant mothers confused and concerned.
As other influential voices offered carefully worded non-responses, Patrick drew on years of research she had been tracking since 2016. In her social media posts following Trump’s announcement, she acknowledged that while autism connections to acetaminophen use during pregnancy aren’t entirely new to the scientific literature, the picture is far more complex than the president’s stark warnings suggested.
“The FDA’s advisory highlights an important association with autism and ADHD that’s been evident in research for years,” Patrick wrote on X, referencing studies she had shared as early as 2016 showing a 30% increase in hyperactivity symptoms among children exposed to acetaminophen during pregnancy.
However, Patrick emphasized the critical nuance missing from Trump’s blanket prohibition: “But autism isn’t monocausal.” She outlined multiple factors that research suggests may contribute to autism spectrum disorders, including maternal inflammation and infections, vitamin D deficiency affecting serotonin synthesis, low omega-3 status impacting brain development, metabolic issues like insulin resistance and obesity, immune dysregulation during pregnancy, BPA and plastic chemical exposure, and sperm epigenetic factors.
This multifaceted explanation stood in sharp contrast to the responses from other high-profile health communicators. Andrew Huberman, the popular neuroscience podcaster, acknowledged the flood of questions he received but offered little substantive guidance.
“Have never received so many calls and text messages about autism as today… phone is blowing up,” Huberman posted, adding only that he planned to “organize a panel, as the R vs L tug o war is driving new parents crazy.”
The scientific community’s measured approach conflicted sharply with the administration’s definitive stance. Even Dr. Mehmet Oz, who stood behind Trump during the Monday announcement, began walking back the absolute prohibition within 24 hours.
In a Tuesday TMZ interview, Oz clarified that pregnant women with high fevers should take Tylenol to lower their body temperature, stating “If you have a high fever….the doctor’s almost certainly going to prescribe you something, Tylenol might be one of the things they give.”
Republican Senator Bill Cassidy, a practicing physician, also pushed back against the administration’s claims, writing on social media: “The preponderance of evidence shows that this is not the case. The concern is that women will be left with no options to manage pain in pregnancy. We must be compassionate to this problem.”
The American College of Obstetricians and Gynecologists has long recommended acetaminophen as one of the few safe pain relievers for pregnant women, making Trump’s blanket prohibition particularly concerning for medical professionals who must balance theoretical risks with real-world pain management needs.
